Co-crystal screening can identify and assess the potential co-crystal forms of an API and provides an alternative approach to modify the physical properties of an API where salts do not achieve the desired performance or are not an option. With state-of-the-art characterization techniques and rich experience in polymorphism screening, scientific experts at Jubilant Biosys can guide through the process of identifying hydrates, solvates, and meta-stable forms of compounds. Our expertise in crystallization enables us to design scalable methods to reliably produce optimum solid form and provide non-GMP material for pre-clinical studies, supporting progression into contract development and manufacturing organization programs.
Compiled from https://www.jubilantbiosys.com
